Initial combination therapy with ambrisentan (AMB) and tadalafil (TAD) in treatment naïve patients with pulmonary arterial hypertension (PAH): Efficacy and safety in the AMBITION study intent to treat (ITT) population

Authors
Category Primary study
JournalEuropean Respiratory Journal
Year 2015
This article has no abstract
Epistemonikos ID: ed2731f1abdc9dbb8554aa44d7225cf58b56bab1
First added on: Feb 07, 2025